Background: Positively reinforcing properties of alcohol are in part mediated by activation of the ventral striatum (VS). Alcohol‐induced release of endogenous opioids is thought to contribute to this response. Preclinical studies show that the opioid antagonist naltrexone (NTX) can block this cascade, but its ability to do so in treatment‐seeking alcoholics has not been examined. Our objective was to study the effects ofNTXon alcohol‐inducedVSactivation and on amygdala response to affective stimuli in treatment‐seeking alcohol‐dependent inpatients.Methods: Sixty‐three treatment‐seeking alcoholics were randomized to receiveNTX(50 mg) or placebo (PLC) daily. On Day 7, participants underwent an alcohol cue reactivity session, and craving was measured using the Penn Alcohol Craving Scale. On Day 9, participants received a saline infusion followed by an alcohol infusion and also viewed affective stimuli in a magnetic resonance scanner.Results: Irrespective of medication treatment condition, the alcohol infusion did not activate theVSin the alcohol‐dependent patients. Unexpectedly,VSactivation was greater inNTXtreated patients than in thePLCgroup.NTXtreated patients also reported increased craving in response to alcohol cue exposure, and increased subjective response to alcohol (“high” and “intoxicated”) compared toPLCsubjects. No significant effects of alcohol infusion on brain response to affective stimuli were in theNTXor PLC groups.Conclusions: Unlike previous findings in social drinkers, a moderate level of intoxication did not activate theVSin treatment‐seeking alcoholics. This is likely to reflect tolerance to the positively reinforcing properties of alcohol in this clinical population. Our findings may help explain the efficacy ofNTXto reduce heavy drinking, but not to maintain abstinence.